IDXG
T. Rowe Price Associates’s Interpace Biosciences, Inc. Common Stock IDXG Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q2 | – | Sell |
-42,000
| Closed | -$11K | – | 2545 |
|
|
2016
Q1 | $11K | Hold |
42,000
| – | – | ﹤0.01% | 2497 |
|
|
2015
Q4 | $21K | Hold |
42,000
| – | – | ﹤0.01% | 2503 |
|
|
2015
Q3 | $75K | Buy |
42,000
+2,000
| +5% | +$3.57K | ﹤0.01% | 2441 |
|
|
2015
Q2 | $57K | Hold |
40,000
| – | – | ﹤0.01% | 2495 |
|
|
2015
Q1 | $54K | Hold |
40,000
| – | – | ﹤0.01% | 2503 |
|
|
2014
Q4 | $72K | Buy |
40,000
+19,600
| +96% | +$35.3K | ﹤0.01% | 2502 |
|
|
2014
Q3 | $49K | Hold |
20,400
| – | – | ﹤0.01% | 2520 |
|
|
2014
Q2 | $89K | Buy |
20,400
+500
| +3% | +$2.18K | ﹤0.01% | 2469 |
|
|
2014
Q1 | $91K | Hold |
19,900
| – | – | ﹤0.01% | 2441 |
|
|
2013
Q4 | $96K | Hold |
19,900
| – | – | ﹤0.01% | 2409 |
|
|
2013
Q3 | $96K | Hold |
19,900
| – | – | ﹤0.01% | 2389 |
|
|
2013
Q2 | $94K | Buy |
+19,900
| New | +$94K | ﹤0.01% | 2350 |
|